DePuy Synthes Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:DePuy Synthes Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7404
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:38
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
DePuy Synthes Inc (DePuy Synthes), a subsidiary of Johnson & Johnson, is a medical device company that provides products for orthopedic and neurological procedures. DePuy Synthes operates through eight divisions: joint reconstruction, sports medicine, neurological, spine, trauma, cranio-maxillofacial, biomaterials, and power tools. The company also offers patient education systems, analytic profiles, ambassador programs, community education programs and other services. DePuy Synthes offers its products to physicians, hospitals, surgeons, caregivers and veterinary industries. The company distributes its products in domestic and international markets. DePuySynthes is headquartered in Warsaw, Indiana, the US.

DePuy Synthes Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
DePuy Synthes Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
DePuy Synthes Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
DePuy Synthes Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
DePuy Synthes Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
DePuy Synthes Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
DePuy Synthes Inc, Medical Equipment, Deal Details 11
Asset Purchase 11
DePuy Synthes Acquires Expandable Cage Technology from Interventional Spine 11
Partnerships 12
DePuy Synthes Enters into Co-Marketing Agreement with JointPoint 12
DePuy Synthes Enters into Co-Marketing Agreement with Medical Enterprises Distribution 13
Aspect Biosystems Partners with DePuy Synthes 14
Codman Neuro Enters into Distribution Agreement with InNeuroCo 15
Materialise Enters into Distribution Agreement with DePuy Synthes 16
DePuy Synthes Enters into Agreement with Radlink 17
DePuy Synthes Enters into Co-Marketing Agreement with Blue Belt for Navio System 18
DePuy Synthes Expands Co-Marketing Agreement With Brainlab 19
DePuy Spine Enters Into Integration Agreement With Brainlab For Surgical And Imaging Solutions 20
Asset Transactions 21
Centinel Spine Acquires Prodisc Assets from DePuy Synthes 21
Biomet Completes Acquisition Of Trauma Business Of Depuy Orthopaedics For US$280 Million 22
Acquisition 23
DePuy Orthopaedics Acquires BioMedical Enterprises 23
DePuy Synthes Acquires Olive Medical 24
DePuy Synthes Inc – Key Competitors 25
DePuy Synthes Inc – Key Employees 26
DePuy Synthes Inc – Locations And Subsidiaries 27
Head Office 27
Other Locations & Subsidiaries 27
Recent Developments 28
Product News 28
Apr 19, 2018: Corail Hip System Collared Femoral Stem Demonstrates a 29% Lower Revision Risk Compared to Class, According to Independent Joint Registry Data 28
Dec 06, 2017: Next-Generation High-Definition Visualization System for Minimally Invasive Surgery Introduced by DePuy Synthes 29
May 31, 2017: Depuy Synthes and Ethicon to Showcase Intra Operative Solutions Aiming to Mitigate Surgical Site Infection During Efort Congress 30
Mar 16, 2017: Mitek Sports Medicine Introduces Comprehensive Knee Arthroscopy Platform for ACL and Meniscal Repair 32
Mar 13, 2017: Ethicon and Depuy Synthes Introduce Customized Wound Closure Kit Aiming to Improve Efficiencies and Patient Outcomes in Orthopaedic Surgery 33
Mar 13, 2017: Ethicon And Depuy Synthes Introduce Customized Wound Closure Kits 34
Other Significant Developments 35
Jan 29, 2018: New Study on Total Hip Arthroplasty (THA) Outcomes with Anterior Approach Show Less Reported Pain, Fewer Narcotics and Better Hip Function in the First 90 Days 35
May 15, 2017: DePuy Synthes Awarded U.S. Department of Defense Contract for Orthopaedic Products 36
Jan 09, 2017: Johnson & Johnson Medical Devices Companies Introduce Orthopaedic Episode of Care Approach, Leveraging CareAdvantage Capabilities to Support Better Clinical Outcomes and Reduce the Cost of Care 37
Appendix 38
Methodology 38
About GlobalData 38
Contact Us 38
Disclaimer 38

List of Tables
DePuy Synthes Inc, Medical Equipment, Key Facts, 2017 2
DePuy Synthes Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
DePuy Synthes Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
DePuy Synthes Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
DePuy Synthes Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
DePuy Synthes Inc, Deals By Market, 2012 to YTD 2018 9
DePuy Synthes Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
DePuy Synthes Acquires Expandable Cage Technology from Interventional Spine 11
DePuy Synthes Enters into Co-Marketing Agreement with JointPoint 12
DePuy Synthes Enters into Co-Marketing Agreement with Medical Enterprises Distribution 13
Aspect Biosystems Partners with DePuy Synthes 14
Codman Neuro Enters into Distribution Agreement with InNeuroCo 15
Materialise Enters into Distribution Agreement with DePuy Synthes 16
DePuy Synthes Enters into Agreement with Radlink 17
DePuy Synthes Enters into Co-Marketing Agreement with Blue Belt for Navio System 18
DePuy Synthes Expands Co-Marketing Agreement With Brainlab 19
DePuy Spine Enters Into Integration Agreement With Brainlab For Surgical And Imaging Solutions 20
Centinel Spine Acquires Prodisc Assets from DePuy Synthes 21
Biomet Completes Acquisition Of Trauma Business Of Depuy Orthopaedics For US$280 Million 22
DePuy Orthopaedics Acquires BioMedical Enterprises 23
DePuy Synthes Acquires Olive Medical 24
DePuy Synthes Inc, Key Competitors 25
DePuy Synthes Inc, Key Employees 26
DePuy Synthes Inc, Other Locations 27
DePuy Synthes Inc, Subsidiaries 27

List of Figures
DePuy Synthes Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
DePuy Synthes Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
DePuy Synthes Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
DePuy Synthes Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
DePuy Synthes Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
DePuy Synthes Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
DePuy Synthes Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
DePuy Synthes Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★海外企業調査レポート[DePuy Synthes Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • EnviTec Biogas AG (ETG):企業の財務・戦略的SWOT分析
    EnviTec Biogas AG (ETG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • NanoString Technologies Inc (NSTG):企業の財務・戦略的SWOT分析
    Summary NanoString Technologies Inc (NanoString) is a developer of life science tools for translational research and molecular diagnostics. The company's products include sprint profiler, Dx analysis system with flex, nCounter MAX analysis system, protein assays, solid tumor assays, gene fusion pane …
  • Blue Moon Zinc Corp.:企業の戦略・SWOT・財務情報
    Blue Moon Zinc Corp. - Strategy, SWOT and Corporate Finance Report Summary Blue Moon Zinc Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • TheraDiag SA (ALTER):製薬・医療:M&Aディール及び事業提携情報
    Summary Theradiag SA (Theradiag), formerly Biomedical Diagnostics SA, is a biotechnology company that develops, manufactures, and markets vitro diagnostic products. The company offers product for the diagnostics of auto-immune diseases, allergies and infectious diseases. It develops product panels f …
  • The Avascent Group:企業の戦略・SWOT・財務情報
    The Avascent Group - Strategy, SWOT and Corporate Finance Report Summary The Avascent Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Genomic Health Inc (GHDX)-医療機器分野:企業M&A・提携分析
    Summary Genomic Health Inc (Genomic Health) is a provider of genomic-based diagnostic tests and clinical laboratory services for the diagnosis of cancer. The company’s commercial product portfolio comprises Onco type DX breast cancer test, Onco type DX colon cancer test, Onco type DX prostate cancer …
  • Super Dragon Technology Co., Ltd. (9955):企業の財務・戦略的SWOT分析
    Super Dragon Technology Co., Ltd. (9955) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • University of Pennsylvania-製薬・医療分野:企業M&A・提携分析
    Summary University of Pennsylvania (UOP) is an educational university that provides distance learning facilities for professional courses. The university offers courses such as art and archaeology, accounting, biochemistry, bioengineering, biomedical graduate studies, city and regional planning, cri …
  • Livescribe Inc:企業の戦略的SWOT分析
    Livescribe Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • J.E. Dunn Construction Group Inc:企業の戦略的SWOT分析
    J.E. Dunn Construction Group Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Comstock Resources Inc (CRK):企業の財務・戦略的SWOT分析
    Summary Comstock Resources Inc (Comstock) is an oil and gas company. It acquires, develops, explores and produces oil and natural gas properties. The company provides oil and gas operations such as Eagle ford Shale, Haynesville Shale and Bakken Shale in North Dakota and Montana; and North Louisiana, …
  • Genesis Energy LP (GEL):石油・ガス:M&Aディール及び事業提携情報
    Summary Genesis Energy LP (Genesis) is a midstream oil and gas company. The company provides services such as offshore pipeline transportation, refinery services, marine transportation, and onshore facilities and transportation. It purchases, transports, stores, blends, and markets crude oil and ref …
  • Assembly Biosciences Inc (ASMB)-製薬・医療分野:企業M&A・提携分析
    Summary Assembly Biosciences Inc (Assembly), formerly Ventrus Biosciences Inc is a biotechnology company that discover, develops and commercializes small molecule therapies. The company develops therapies for the treatment of infectious diseases such as chronic hepatitis B virus (HBV) and microbioti …
  • Glori Energy Inc:石油・ガス:M&Aディール及び事業提携情報
    Summary Glori Energy Inc (Glori Energy) is an energy technology and an oil production company. The company deploys proprietary technology to increase the amount of oil that can be produced from conventional oil fields which it marketed to third party exploration and production companies. It also own …
  • HSH Nordbank Private Banking:企業の戦略・SWOT・財務情報
    HSH Nordbank Private Banking - Strategy, SWOT and Corporate Finance Report Summary HSH Nordbank Private Banking - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Rinnai Corp (5947):企業の財務・戦略的SWOT分析
    Rinnai Corp (5947) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Eurobio Scientific SA (ALEHT):企業の財務・戦略的SWOT分析
    Summary Eurobio Scientific SA (Eurobio), formerly Diaxonhit SA, a subsidiary of Hellenic Petroleum SA, is a biotechnology company that provides diagnostic products. The company provides products such as TQS, used in treatment of teanus and BJI InoPlex, used for the treatment of prosthetic infection. …
  • Serco Group plc:企業の戦略・SWOT・財務情報
    Serco Group plc - Strategy, SWOT and Corporate Finance Report Summary Serco Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Allergy Therapeutics Plc (AGY):企業の財務・戦略的SWOT分析
    Allergy Therapeutics Plc (AGY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Angelini Group:製薬・医療:M&Aディール及び事業提携情報
    Summary Angelini Group (Angelini) manufactures, markets and distributes pharmaceutical and healthcare products. The company operates in prescription and over-the-counter (OTC) pharmaceutical sectors with focus on pain and inflammation disorders, infection control and infectious diseases and central …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆